Scorpion Therapeutics logo

Scorpion Therapeutics, Inc.


Scorpion Therapeutics Stock

Scorpion Therapeutics aims to reshape cancer treatment with itsPrecision Oncology 2.0 approach. This strategy focuses on three key areas: targeting known, underserved cancer drivers, drugging previously undruggable targets, and discovering novel targets with high therapeutic potential.

Management Team

Adam Friedman, MD, Ph.D. CEO
Mark Chao, MD, Ph.D. Chief Medical Officer
Erica L. Jackson, Ph.D. Chief Discovery Officer
Brian Piper CFO
Kristin Schuhwerk COO
Darrin Stuart, Ph.D. Chief Scientific Officer
Amanda Valentino Chief People Officer

Funding Information